Regina Salvat, PhD, is a Principal in the Boston office.
Regina joins Forbion from Sofinnova Investments, where she has been driving multiple successful, private investments. She has a PhD in protein engineering from Dartmouth College, and a degree in Biomedical engineering from Cornell University.
Regina has already collaborated with Forbion on a number of successful investments, including Gyroscope and Capstan Therapeutics. At Forbion, Regina concentrates on Growth strategies building on her extensive experience and network. She currently serves on the board of Marea Therapeutics.
Forbion is a fantastic firm to work for — it fosters a highly collaborative environment with a strong, supportive culture. We tackle high-impact problems that directly affect human health.
